Inovio Pharmaceuticals, Inc. (INO)
NASDAQ·Healthcare·Biotechnology
$1.25
-2.73%
Mkt Cap $86.36M
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (7 analysts)
$2.75
Range $2.50 – $3.00
Implied Upside
+120.0%
Consensus $2.75 vs current $1.25
NASDAQ·Healthcare·Biotechnology
$1.25
-2.73%
Mkt Cap $86.36M
Buy
2
Hold
1
Sell
0
Price Target (7 analysts)
$2.75
Range $2.50 – $3.00
+120.0%
Consensus $2.75 vs current $1.25